Updated survival, toxicity, and biomarkers of nivolumab with/without peptide vaccine in patients naive to, or progressed on, ipilimumab (IPI).Jeffrey S. Weber, Ann Chen, Geoffrey T. Gibney et al.|Journal of Clinical Oncology|2014Cited by 14